Better shared decision-making could help patients feel more empowered, avoid treatment side-effects and reduce overtreatment.
Michigan Medicine experts discuss whether active surveillance — close monitoring without immediate treatment — could reduce overtreatment for some thyroid, prostate and breast cancer patients.
A large, population-based study identifies three groups most at risk of postoperative complications.
A large study shows bone complications in thyroid cancer are an indicator of a poor prognosis, suggesting the need for more drug research.
In recent years, the use of imaging tests has skyrocketed for post-treatment surveillance of thyroid cancer. But this hasn’t affected survival rates, new research shows.